405 related articles for article (PubMed ID: 27045883)
21. Gender differences in multiple sclerosis epidemiology and treatment response.
Magyari M
Dan Med J; 2016 Mar; 63(3):. PubMed ID: 26931196
[TBL] [Abstract][Full Text] [Related]
22. An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis.
Handel AE; Williamson AJ; Disanto G; Handunnetthi L; Giovannoni G; Ramagopalan SV
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824132
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus and multiple sclerosis.
Lucas RM; Hughes AM; Lay ML; Ponsonby AL; Dwyer DE; Taylor BV; Pender MP
J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1142-8. PubMed ID: 21836034
[TBL] [Abstract][Full Text] [Related]
24. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
25. Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs.
Portaccio E; Ghezzi A; Hakiki B; Sturchio A; Martinelli V; Moiola L; Patti F; Mancardi GL; Solaro C; Tola MR; Pozzilli C; De Giglio L; Totaro R; Lugaresi A; De Luca G; Paolicelli D; Marrosu MG; Comi G; Trojano M; Amato MP;
J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):845-50. PubMed ID: 24403285
[TBL] [Abstract][Full Text] [Related]
26. Environmental factors in multiple sclerosis: Epstein-Barr virus, vitamin D, and cigarette smoking.
Wingerchuk DM
Mt Sinai J Med; 2011; 78(2):221-30. PubMed ID: 21425266
[TBL] [Abstract][Full Text] [Related]
27. The relationship between stress and disease onset and relapse in multiple sclerosis: A systematic review.
Jiang J; Abduljabbar S; Zhang C; Osier N
Mult Scler Relat Disord; 2022 Nov; 67():104142. PubMed ID: 36155965
[TBL] [Abstract][Full Text] [Related]
28. Infectious mononucleosis and multiple sclerosis - Updated review on associated risk.
Sheik-Ali S
Mult Scler Relat Disord; 2017 May; 14():56-59. PubMed ID: 28619433
[TBL] [Abstract][Full Text] [Related]
29. Association between human herpesvirus & human endogenous retrovirus and MS onset & progression.
Tao C; Simpson S; Taylor BV; van der Mei I
J Neurol Sci; 2017 Jan; 372():239-249. PubMed ID: 28017222
[TBL] [Abstract][Full Text] [Related]
30. Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis.
Thacker EL; Mirzaei F; Ascherio A
Ann Neurol; 2006 Mar; 59(3):499-503. PubMed ID: 16502434
[TBL] [Abstract][Full Text] [Related]
31. Environmental factors and their interactions with risk genotypes in MS susceptibility.
Hedström AK; Alfredsson L; Olsson T
Curr Opin Neurol; 2016 Jun; 29(3):293-8. PubMed ID: 27035899
[TBL] [Abstract][Full Text] [Related]
32. Multiple sclerosis and pregnancy.
Tsui A; Lee MA
Curr Opin Obstet Gynecol; 2011 Dec; 23(6):435-9. PubMed ID: 22011954
[TBL] [Abstract][Full Text] [Related]
33. Multiple sclerosis: risk factors and their interactions.
Disanto G; Morahan JM; Ramagopalan SV
CNS Neurol Disord Drug Targets; 2012 Aug; 11(5):545-55. PubMed ID: 22583442
[TBL] [Abstract][Full Text] [Related]
34. Modifiable factors influencing relapses and disability in multiple sclerosis.
D'hooghe MB; Nagels G; Bissay V; De Keyser J
Mult Scler; 2010 Jul; 16(7):773-85. PubMed ID: 20483884
[TBL] [Abstract][Full Text] [Related]
35. What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature.
Finkelsztejn A; Brooks JB; Paschoal FM; Fragoso YD
BJOG; 2011 Jun; 118(7):790-7. PubMed ID: 21401856
[TBL] [Abstract][Full Text] [Related]
36. Multiple sclerosis and antecedent infections: a case-control study.
Marrie RA; Wolfson C; Sturkenboom MC; Gout O; Heinzlef O; Roullet E; Abenhaim L
Neurology; 2000 Jun; 54(12):2307-10. PubMed ID: 10881258
[TBL] [Abstract][Full Text] [Related]
37. [Smoking and multiple sclerosis].
Arruti M; Castillo-Triviño T; Egüés N; Olascoaga J
Rev Neurol; 2015 Feb; 60(4):169-78. PubMed ID: 25670047
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention-An Update.
Ascherio A; Munger KL
Semin Neurol; 2016 Apr; 36(2):103-14. PubMed ID: 27116717
[TBL] [Abstract][Full Text] [Related]
39. Epidemiological investigation of the association between infectious mononucleosis and multiple sclerosis.
Lindberg C; Andersen O; Vahlne A; Dalton M; Runmarker B
Neuroepidemiology; 1991; 10(2):62-5. PubMed ID: 2062419
[TBL] [Abstract][Full Text] [Related]
40. Latitude, sun exposure and vitamin D supplementation: associations with quality of life and disease outcomes in a large international cohort of people with multiple sclerosis.
Jelinek GA; Marck CH; Weiland TJ; Pereira N; van der Meer DM; Hadgkiss EJ
BMC Neurol; 2015 Aug; 15():132. PubMed ID: 26243188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
